Skip to content

Prospective Evaluation of the Efficacy and Safety of Endoscopic Tissue Apposition

Prospective Evaluation of the Efficacy and Safety of Endoscopic Tissue Apposition

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03626194
Enrollment
500
Registered
2018-08-10
Start date
2016-12-12
Completion date
2026-12-16
Last updated
2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bariatric Endoscopy, Endoscopic Clipping, Endoscopic Sleeve Gastroplasty, Endoscopic Suturing, Endoscopic Tissue Apposition, Transoral Outlet Reduction

Brief summary

This study is a prospective registry of patients undergoing endoscopic suturing and/or clip placement at our institution to assess the efficacy and safety of endoscopic tissue apposition. 1.1 Hypothesis: Endoscopic tissue apposition is efficacious and safe in the practice of gastrointestinal endoscopy. 1.2 Aims: To prospectively evaluate the efficacy and safety of Endoscopic Tissue Apposition in the practice of gastrointestinal endoscopy.

Interventions

None listed

Sponsors

University of Colorado, Denver
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

* Patients\>18 years of age undergoing endoscopy for any of the following indications: Indications for Tissue Apposition: * Closure of perforations * Closure of full thickness defects created during endoscopic full thickness resection * Closure of defects after endoscopic submucosal dissection and endoscopic mucosal resection * Closure of mucosotomy after Peroral Endoscopic Myotomy (POEM) * Stent fixation * Closure of fistulas * Natural Orifice Transluminal Endoscopic Surgery defect closures * Post-bariatric surgery gastrojejunal anastomosis and gastric pouch revision (transoral outlet repair) * Primary endoscopic sleeve gastroplasty

Exclusion criteria

* Patients unable or unwilling to provide consent * Pregnant patients * Coagulation disorders (INR \>1.8, platelet \<50,000) * GI Bleeding * Hemodynamic instability * Enrollment in another device or drug study that may confound the results

Design outcomes

Primary

MeasureTime frameDescription
Technical and clinical success in endoscopic tissue appositionFrom baseline to one yearSuccessful completion of endoscopic suturing/clipping and measured as clinical symptom improvement as well as objective evidence of resolution / improvement of underlying pathology / confirmed with radiologic contrast studies as needed..
Adverse EventsFrom baseline to one yearBased on ASGE criteria

Countries

United States

Contacts

Primary ContactAbigail Lowe
ABIGAIL.LOWE@UCDENVER.EDU303-724-6070

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026